OHERZYO
Live / Applied — Third extension granted (statement of use) (as of 14 Jan 2026)
What this means for you
Not registered yet, but its 09 Jan 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98349208
- Mark type
- Stylized text
- Filed
- 09 Jan 2024
- Published for opposition
- 25 Jun 2024
- Attorney of record
- Monica Riva Talley
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceuticals for the treatment of cancer
Owner
- BioNTech SE, Mainz, DE
- BioNTech SE, Mainz, DE
Prosecution history
- 15 Jan 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 14 Jan 2026 — SOU EXTENSION 3 GRANTED
- 14 Jan 2026 — SOU EXTENSION 3 FILED
- 14 Jan 2026 — SOU TEAS EXTENSION RECEIVED
- 13 Aug 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 12 Aug 2025 — SOU EXTENSION 2 GRANTED
- 12 Aug 2025 — SOU EXTENSION 2 FILED
- 12 Aug 2025 — SOU TEAS EXTENSION RECEIVED
- 12 Feb 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 11 Feb 2025 — SOU EXTENSION 1 GRANTED
- 11 Feb 2025 — SOU EXTENSION 1 FILED
- 11 Feb 2025 — SOU TEAS EXTENSION RECEIVED
- 20 Aug 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 12 Jul 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 25 Jun 2024 — PUBLISHED FOR OPPOSITION